MedPath

青州尧王制药有限公司

Ownership
-
Established
1992-12-21
Employees
-
Market Cap
-
Website
http://www.qzywzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

98

NMPA:98

Drug Approvals

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20093316
Approval Date
Sep 11, 2023
NMPA

Fluorouracil and Sodium Chloride Injection

Product Name
普力达
Approval Number
国药准字H20041514
Approval Date
Sep 11, 2023
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20093315
Approval Date
Sep 11, 2023
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20093317
Approval Date
Sep 11, 2023
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20093318
Approval Date
Sep 11, 2023
NMPA

Homoharringtonine and Sodium Chloride Injection

Product Name
川山宁
Approval Number
国药准字H20040224
Approval Date
Sep 11, 2023
NMPA

Indometacin Cataplasms

Product Name
吲哚美辛凝胶贴膏
Approval Number
国药准字H20183370
Approval Date
Jun 24, 2023
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20073635
Approval Date
Jun 22, 2022
NMPA

Mezlocillin Sodium for Injection

Product Name
注射用美洛西林钠
Approval Number
国药准字H20113253
Approval Date
Mar 23, 2021
NMPA

Mezlocillin Sodium for Injection

Product Name
注射用美洛西林钠
Approval Number
国药准字H20113252
Approval Date
Mar 23, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.